Tamao Nakashita
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tamao Nakashita has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Shinji Motojima
Department of Rheumatology, Kameda Medical Center, 929 Higashi-Cho, Kamogawa-City, Chiba 296-8602, Japan
3 shared publications - Katsutoshi Ando
Division of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-Ku, Tokyo 113-8421, Japan
2 shared publications - Kazuhisa Takahashi
Department of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan
2 shared publications - Norihiro Kaneko
Respiratory Internal Medicine, Kameda Medical Center, 929 Higashi-Cho, Kamogawa-City, Chiba 296-8602 Japan
2 shared publications - Kei Nakasima
Department of Pulmonology, Kameda Medical Center, 296-8602, 929 higashi-cho, Kamogawa-city, Chiba, Japan
1 shared publication - Nobuhiro Asai
Department of Pulmonology, Kameda Medical Center, Chiba, Japan
1 shared publication
Latest Publications
- 1 September 2016
- Published by Elsevier in Respiratory Investigation
- Vol. 54 (5) , 376-379
Possible effect of abatacept on the progression of interstitial lung disease in rheumatoid arthritis patients
- 1 September 2016
- Published by Elsevier in Respiratory Investigation
- Vol. 54 (5) , 376-379
Possible effect of abatacept on the progression of interstitial lung disease in rheumatoid arthritis patients
- Open Access
- 23 August 2016
- Published by Springer Nature in SpringerPlus
- Vol. 5 (1) , 1-8
Associations between peripheral blood eosinophil counts in patients with systemic sclerosis and disease severity
Increased levels of serum pro-fibrotic cytokines have been reported in patients with systemic sclerosis (SSc). Some of these cytokines also play an important role in the differentiation and migration of eosinophils. The aim of this study was to determine whether eosinophilic inflammation is caused in SSc. We retrospectively reviewed the peripheral blood eosinophil counts in 70 untreated patients with SSc and compared them with those in patients with other major collagen diseases. We additionally evaluated a possible association with disease severity. Eosinophil counts were significantly higher levels in patients with SSc than in those with other collagen diseases, whereas total leukocyte counts were not. Eosinophil counts correlated positively with both severe interstitial lung disease (ILD; r = 0.255, p = 0.033) and modified Rodnan total skin thickness score (m-Rodnan TSS) in SSc (r = 0.347, p = 0.003), but did not correlate with ILD severity in other collagen diseases. In conclusion, peripheral eosinophil counts were higher in patients with SSc than in those with other collagen diseases and were correlated with increased disease severity. Our data suggest that eosinophilic inflammation is involved in the pathogenesis and progression of SSc.
- 23 August 2016
- Published by Springer Nature in SpringerPlus
- Vol. 5 (1) , 1-8
Open AccessAssociations between peripheral blood eosinophil counts in patients with systemic sclerosis and disease severity
Increased levels of serum pro-fibrotic cytokines have been reported in patients with systemic sclerosis (SSc). Some of these cytokines also play an important role in the differentiation and migration of eosinophils. The aim of this study was to determine whether eosinophilic inflammation is caused in SSc. We retrospectively reviewed the peripheral blood eosinophil counts in 70 untreated patients with SSc and compared them with those in patients with other major collagen diseases. We additionally evaluated a possible association with disease severity. Eosinophil counts were significantly higher levels in patients with SSc than in those with other collagen diseases, whereas total leukocyte counts were not. Eosinophil counts correlated positively with both severe interstitial lung disease (ILD; r = 0.255, p = 0.033) and modified Rodnan total skin thickness score (m-Rodnan TSS) in SSc (r = 0.347, p = 0.003), but did not correlate with ILD severity in other collagen diseases. In conclusion, peripheral eosinophil counts were higher in patients with SSc than in those with other collagen diseases and were correlated with increased disease severity. Our data suggest that eosinophilic inflammation is involved in the pathogenesis and progression of SSc.
- Open Access
- 11 June 2012
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 7 (1) , 2
Non-HIV Pneumocystis pneumonia: do conventional community-acquired pneumonia guidelines under estimate its severity?
Non-HIV Pneumocystis pneumonia (PCP) can occur in immunosuppressed patients having malignancy or on immunosuppressive agents. To classify severity, the A-DROP scale proposed by the Japanese Respiratory Society (JRS), the CURB-65 score of the British Respiratory Society (BTS) and the Pneumonia Severity Index (PSI) of the Infectious Diseases Society of America (IDSA) are widely used in patients with community-acquired pneumonia (CAP) in Japan. To evaluate how correctly these conventional prognostic guidelines for CAP reflect the severity of non-HIV PCP, we retrospectively analyzed 21 patients with non-HIV PCP.
- 11 June 2012
- Published by Mattioli1885 in Multidisciplinary Respiratory Medicine
- Vol. 7 (1) , 2
Open AccessNon-HIV Pneumocystis pneumonia: do conventional community-acquired pneumonia guidelines under estimate its severity?
Non-HIV Pneumocystis pneumonia (PCP) can occur in immunosuppressed patients having malignancy or on immunosuppressive agents. To classify severity, the A-DROP scale proposed by the Japanese Respiratory Society (JRS), the CURB-65 score of the British Respiratory Society (BTS) and the Pneumonia Severity Index (PSI) of the Infectious Diseases Society of America (IDSA) are widely used in patients with community-acquired pneumonia (CAP) in Japan. To evaluate how correctly these conventional prognostic guidelines for CAP reflect the severity of non-HIV PCP, we retrospectively analyzed 21 patients with non-HIV PCP.